Public Profile

Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals, Inc., a prominent player in the ophthalmic pharmaceutical industry, is headquartered in the United States. Founded in 2008, the company has rapidly established itself as a leader in developing innovative therapies for eye diseases, particularly glaucoma and retinal disorders. Aerie's core products, including the unique eye drops Rhopressa® and Rocklatan®, are designed to lower intraocular pressure, setting them apart in a competitive market. With a strong focus on research and development, Aerie has achieved significant milestones, including successful product launches and expanding its operational footprint across North America and Europe. The company’s commitment to advancing eye care has positioned it favourably within the industry, earning recognition for its contributions to improving patient outcomes and enhancing the quality of life for those affected by vision-related conditions.

DitchCarbon Score

How does Aerie Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Aerie Pharmaceuticals, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Aerie Pharmaceuticals, Inc.'s reported carbon emissions

Aerie Pharmaceuticals, Inc., headquartered in the US, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate commitments, often setting ambitious targets to reduce their carbon footprint across Scope 1, 2, and 3 emissions. However, without specific data or commitments from Aerie Pharmaceuticals, it is unclear how they are addressing climate change or their carbon emissions. As the industry evolves, stakeholders may look for Aerie to establish clear climate strategies and reduction initiatives in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aerie Pharmaceuticals, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aerie Pharmaceuticals, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Aerie Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Alcon

CH
Health and social work services (85)
Updated 21 minutes ago

Novartis International AG

CH
Real estate services (70)
Updated 3 months ago
DitchCarbon Score

Sandoz International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Abbvie

US
Chemicals nec
Updated 1 minute ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers